Trial Profile
Flucloxacillin vs diclofenac in volunteers with successful sugammadex reversal of rocuronium- or vecuronium-induced neuromuscular blockade
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2012
Price :
$35
*
At a glance
- Drugs Diclofenac; Flucloxacillin; Rocuronium bromide; Sugammadex; Vecuronium bromide
- Indications Bacterial infections; Pain
- Focus Adverse reactions
- Sponsors Merck Sharp & Dohme
- 01 Mar 2012 Results published in Clinical Drug Investigation.
- 22 Feb 2012 New trial record